Clinical trial
Effects of Sitagliptin on Arterial Vasoreactivity and Proatherogenic Mediators in Obesity
NCT02576288 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Sitagliptin on Arterial Vasoreactivity and Proatherogenic Mediators in Obesity
- Lead sponsor
- University of Southern California
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- December 31, 2017
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.